Skip to content
Open access

Explainable AD classification using integrated quantum-inspired deep neural and transformer models

Aug 2026 · Scientific Reports · 0 citations

TL;DR

An explainable and robust classification framework that will be able to retain its performance under in-distribution and blind-testing settings and validating its generalization ability of domain shift is proposed.

Abstract

The classification of Alzheimer’s disease (AD) is often not consistent and reliable due to heterogeneous neurodegenerative patterns and the non-generalization of various imaging sources. This study proposes an explainable and robust classification framework that will be able to retain its performance under in-distribution and blind-testing settings. The study uses 4 publicly available brain MRI datasets covering several stages of AD including non-demented, mild cognitive impairment and progressive Alzheimer’s stages. The datasets consist of balanced and augmented scans, and clinically heterogeneous scans were acquired using different imaging and acquisition techniques. A dedicated independent dataset is used for blind evaluation to check robustness against unseen-source domain shifts. An explainable hybrid framework, named Tri-Fusion-ADNet, is proposed in this work. It consists of EfficientNet-V2-S for localized neuro-anatomical feature extraction, Swin TransformerV2 for modelling long-range contextual dependencies and a quantum-inspired variational neural network (QI-VNN) for enhanced interaction of higher-order features. Before the classification, fusion has been done on feature levels. The reliability of the model is checked through 10-fold cross-validation on various datasets. Further, qualitative interpretability has been supported through visualization using Grad-CAM.The proposed Tri-Fusion-ADNet performed well in all data sets. The testing accuracy of the model was 98.42% (MCC = 0.979) on the balanced augmented dataset (D-I). The accuracy was 97.86% (MCC = 0.973) on augmented dataset (D-II). The clinically heterogeneous dataset (D-III) gave 96.21% (MCC = 0.949). Also, 91.18 when trained on D-I and tested on D-II, and 91.64 when trained on D-II and tested on D-I, cross-dataset testing without adaptation yields very high accuracies. In addition, during blind cross-dataset evaluation on an independent unseen dataset (D-IV), the framework maintained a robust accuracy of 91.22%, validating its generalization ability of domain shift.

Read PDF

Similar papers

Open access Sep 2026

A multi-architecture deep learning ensemble approach for Parkinson’s disease classification from structural brain MRI

Parkinson’s disease (PD) is a progressive neurodegenerative disorder in which early diagnosis remains challenging because structural changes observed on magnetic resonance imaging (MRI) are often subtle. This study presents a deep learning framework for PD classification from structural brain MRI using six complementar...

Jeevana Jyothi Pujari, Thulasi Bikku, Kommerla Siva Kumar et al. · 0 citations
Open access Aug 2026

Enhanced Alzheimer’s Disease Detection Using Transformer-Based GAN and Deep Learning Techniques

Early detection of Alzheimer’s Disease (AD) is essential for timely clinical intervention. However, conventional Magnetic Resonance Imaging-based (MRI-based) diagnostic approaches are often limited by class imbalance, insufficient training data, inter-dataset variability, and inadequate feature extraction capability, w...

Ibrahim Mohammed Madhat, Farhan Mohamed, Omar Albebashy et al. · 0 citations
Open access Aug 2026

Bridging Accuracy and Interpretability: Explainable Deep Learning for Parkinson’s Disease Diagnosis from MRI

The results demonstrate that combining adaptive preprocessing, patient-wise evaluation, and explainable deep learning holds promise for MRI-based Parkinson’s disease detection under a preliminary, dataset-specific evaluation, though substantial performance variability remains across different subject selections, rather...

Ioana-Teodora Isar, Nirvana Popescu · 0 citations
Sep 2026

NeuroFusion: A Multimodal Transformer Framework for Early and Explainable Detection of Alzheimer’s Disease

Alzheimer's disease (AD) is a progressive neurodegenerative disorder, and a great deal of pathological changes can be observed in the early stages of the disease before significant cognitive function is clinically evident. In this study, a multimodal Transformer framework named NeuroFusion for early and explainable det...

Mintu Debnath · 0 citations
Open access Sep 2026

Quantum-enhanced deep learning for Parkinson’s disease classification

Parkinson’s disease (PD) involves a slowly advancing neurological condition that profoundly impairs motor as well as cognitive abilities, making prompt and precise diagnosis essential for successful treatment. Diagnosing PD using MRI images is difficult because of subtle changes within the brain and imbalanced datase...

Kagitha Samitha, V. K, G. P. Reddy et al. · 0 citations
Conference Aug 2026

X-AstroNet: Explainable Adaptive Token Fusion via Hybrid Convolutional-Swin Transformer Pipelines for Alzheimer's Stage Identification

The challenge of early detection of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) is a neuroimaging challenge that has not been solved yet, as conventional deep learning architectures are not well suited to extract fine-grained localized features from the image while preserving the long-range structural...

S. Lokesh, P. Muthukumaraswamy, S. Priyan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.